LDDM: 3D generative model designs novel drug hits validated by X-ray across 5 targets
mmbronstein · x · 2026-09-19
- A team from EPFL, UCSF and partners (Igashov, Bronstein, Correia et al.) released LDDM, a unified 3D generative model for synthesizable structure-based drug design (SBDD), on bioRxiv.
- Key results: experimentally validated across 5 targets, designing novel hits with structural accuracy confirmed by X-ray crystallography — beyond purely computational validation common in generative drug design.
- Preprint: doi 10.64898/2026.09.15.751537.
More from Research
- Stabilizing RL with a simple second-year probability trick: the covariance identity — PMinervini · 2026-09-19
- willcb: in-context learning for personal continual learning needs neurosymbolic harnesses — willcb · 2026-09-19
- Online RL via task flywheels from live interaction traces is what actually works today — willcb · 2026-09-19
- Tobi Lütke sparks debate: why discriminative models can't be universal classifiers — caglar_ee · 2026-09-19
- Hidden tests + code review benchmark: Sonnet 5 scores 95.0, beating Opus 4.6 and local Qwen 3.8 27B — Short_Regular_7191 · 2026-09-19
- 10 Machine Learning Books That Build Real Understanding, From Goodfellow to Chip Huyen — thisguyknowsai · 2026-09-19